Skip to main content

Table 1 Characteristics of the responders and nonresponders

From: Diagnoses and prescription patterns among users of medications for obstructive airway diseases in Finland

  

Responders

Nonresponders

p value

Total

N (% of the corrected total sample)

803 (40.6)

1175 (59.4)

n/a

Females

N (%)

492 (61.3)

642 (54.6)

0.003

Agea

Years

62 (50–70)

54 (41–66)

 < 0.001

BMIa

kg/m2

27.3 (24.4–31.3)

n/a

n/a

Smoking statusb

N (%)

 

n/a

n/a

 Current

 

120 (14.9)

  

 Former

 

269 (33.5)

  

 Never

 

411 (51.2)

  

Number of subjects dispensed different drug classes

N (%)

   

 ICS

 

662 (82.4)

854 (72.7)

 < 0.001

 LTRA

 

116 (14.4)

115 (9.8)

0.002

 LABA

 

397 (49.4)

518 (44.1)

0.019

 LAMA

 

78 (9.7)

119 (10.1)

0.763

 SABA

 

513 (63.9)

771 (65.6)

0.428

 SAMA

 

10 (1.2)

17 (1.4)

0.705

 Theophylline

 

7(0.9)

14 (1.2)

0.496

 Roflumilast

 

1(0.1)

3 (0.3)

0.525

  1. ICS Inhaled corticosteroid, LABA Long-acting beta-agonist, LAMA Long-acting muscarinic antagonist, LTRA Leukotriene receptor antagonist, OCS Oral corticosteroid, SABA Short-acting beta-agonist, SAMA Short-acting muscarinic antagonist
  2. aMedian with IQR
  3. bSubjects with complete answers regarding smoking habits